Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yavuz S Dagdas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nanotechnology|June 16, 2011
Nanomechanical characterization by double-pass force-distance mappingYavuz S Dagdas, M Necip Aslan, Ayse B Tekinay, et al.
Elife|October 13, 2015
Single-molecule imaging of telomerase reverse transcriptase in human telomerase holoenzyme and minimal RNP complexesRobert Alexander Wu, Yavuz S Dagdas, S Tunc Yilmaz, et al.
Science Advances|August 16, 2017
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9Yavuz S Dagdas, Janice S Chen, Samuel H Sternberg, et al.
Advanced Drug Delivery Reviews|January 27, 2022
Engineering interferons and interleukins for cancer immunotherapyPatrick G Holder, Shion A Lim, Christine S Huang, et al.
Nature|September 21, 2017
Enhanced proofreading governs CRISPR-Cas9 targeting accuracyJanice S Chen, Yavuz S Dagdas, Benjamin P Kleinstiver, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nanotechnology|June 16, 2011
Nanomechanical characterization by double-pass force-distance mappingYavuz S Dagdas, M Necip Aslan, Ayse B Tekinay, et al.
Elife|October 13, 2015
Single-molecule imaging of telomerase reverse transcriptase in human telomerase holoenzyme and minimal RNP complexesRobert Alexander Wu, Yavuz S Dagdas, S Tunc Yilmaz, et al.
Science Advances|August 16, 2017
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9Yavuz S Dagdas, Janice S Chen, Samuel H Sternberg, et al.
Advanced Drug Delivery Reviews|January 27, 2022
Engineering interferons and interleukins for cancer immunotherapyPatrick G Holder, Shion A Lim, Christine S Huang, et al.
Nature|September 21, 2017
Enhanced proofreading governs CRISPR-Cas9 targeting accuracyJanice S Chen, Yavuz S Dagdas, Benjamin P Kleinstiver, et al.
Pageof 1